Karma Biotechnologies (Seed+)
Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
- $8,000,000
Company Info
- Founders
- Andrew Gray
- Company Description
- Biotechnology company that developed Xavine vaccine platform to solve autoimmune diseases. Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.
- Market
- Healthcare & Wellness
- Coinvestors
- Freeflow,Khosla Ventures,SOSV